REQUEST A DEMO
Total
USD $0.00
Search more companies

Exlab Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Exlab Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Exlab Company Limited is an enterprise located in Thailand, with the main office in Bangkok , Special Governed District of. It operates in the Pharmaceutical Preparation Manufacturing industry. Exlab Company Limited was incorporated on May 15, 2026. It currently has a total number of 131 (estimated) employees. The company’s latest financial report indicates a net sales revenue increase of 5.14% in 2024. Its’ total assets recorded a growth of 19.76%. The net profit margin of Exlab Company Limited decreased by 0.09% in 2024.

Headquarters
26/6 Lat Phrao Road Soi Lat Phrao 122 (Mahadthai 1)
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10310

Contact Details: Purchase the Exlab Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Exlab Company Limited report to view the information.
Financial Auditors:
Purchase the Exlab Company Limited report to view the information.
Incorporation Date:
May 15, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Exlab Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
5.14%
Total Operating Revenue
5.14%
Operating Profit
4.96%
EBITDA
4.96%
Net Profit/Loss for the Period
3.94%
Total Assets
19.76%
Total Equity
13.88%
Operating Profit Margin
-0.02%
Net Profit Margin
-0.09%
Return on Equity (ROE)
-1.17%
Quick Ratio
-2.51%
Cash Ratio
-0.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?